论文部分内容阅读
临床资料本组重症肺炎111例,年龄40天～3岁.其中心衰107例,呼吸衰竭53例,DIC33例,脑病21例,消化道出血12例.以上病例均符合卫生部颁布诊断标准.111例随机分为两组.对照组44例中并发DIC者使用肝素;治疗组67例全部使用肝素.剂量每次0.25～0.5mg/kg缓慢静注,2～4小时1次,每天2～6次,一般不超过3天.疗效判定标准:1.显效:3天内肺部体征迅速改善,并发症完全消失,治愈.2.有效:3天后肺部体征逐步改善,并发症相继消失,治愈.3.无效:肺部体征无改善,并发症加重或增多,死亡.
Clinical data of this group of 111 cases of severe pneumonia, aged 40 days to 3 years of age.Its heart failure in 107 cases, 53 cases of respiratory failure, DIC33 cases, 21 cases of encephalopathy, gastrointestinal bleeding in 12. All cases are in line with the Ministry of Health promulgated diagnostic criteria. 111 cases were randomly divided into two groups.The control group of 44 patients with concurrent DIC heparin; the treatment group of 67 patients with heparin.Dose 0.25 ~ 0.5mg / kg slowly intravenous infusion, 2 to 4 hours 1, 2 ~ 6 times, generally not more than 3 days .Clinical criteria: 1. Markedly: 3 days rapid improvement of lung signs, complications completely disappear, cure .2 Effective: 3 days after the gradual improvement of lung signs, complications have disappeared, the cure .3 invalid: no improvement in lung signs, complications or increase, death.